The evolution of antimicrobial peptide resistance in Pseudomonas aeruginosa is shaped by strong epistatic interactions
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Colistin is an antimicrobial peptide that has become the only remaining alternative for the treatment of multidrug-resistant Gram-negative bacterial infections, but little is known of how clinical levels of colistin resistance evolve. We use in vitro experimental evolution and whole-genome sequencing of colistin-resistant Pseudomonas aeruginosa isolates from cystic fibrosis patients to reconstruct the molecular evolutionary pathways open for high-level colistin resistance. We show that the evolution of resistance is a complex, multistep process that requires mutation in at least five independent loci that synergistically create the phenotype. Strong intergenic epistasis limits the number of possible evolutionary pathways to resistance. Mutations in transcriptional regulators are essential for resistance evolution and function as nodes that potentiate further evolution towards higher resistance by functionalizing and increasing the effect of the other mutations. These results add to our understanding of clinical antimicrobial peptide resistance and the prediction of resistance evolution.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wiegand, I., Hilpert, K., & Hancock, R. E. W. (2008) · Nature Protocols · doi:10.1038/nprot.2007.521 · Cited by 6,156
Evolutionary paths to antibiotic resistance under dynamically sustained drug selection
Toprak, E., Veres, A., Michel, J.-B., Chait, R., Hartl, D. L., & Kishony, R. (2012) · Nature Genetics · doi:10.1038/ng.1034 · Cited by 764
Genomic analysis of a key innovation in an experimental Escherichia coli population
Blount, Z. D., Barrick, J. E., Davidson, C. J., & Lenski, R. E. (2012) · Nature · doi:10.1038/nature11514 · Cited by 612
The contribution of epistasis to the architecture of fitness in an RNA virus
Sanjuán, R., Moya, A., & Elena, S. F. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404125101 · Cited by 233
Cited by
Antimicrobial peptides: Application informed by evolution
Lazzaro, B. P., Zasloff, M., & Rolff, J. (2020) · Science · doi:10.1126/science.aau5480 · Cited by 1,069
Contingency and determinism in evolution: Replaying life’s tape
Blount, Z. D., Lenski, R. E., & Losos, J. B. (2018) · Science · doi:10.1126/science.aam5979 · Cited by 590
Antibiotic resistance in Pseudomonas aeruginosa – Mechanisms, epidemiology and evolution
Botelho, J., Grosso, F., & Peixe, L. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.07.002 · Cited by 550
Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis
Rossi, E., La Rosa, R., Bartell, J. A., Marvig, R. L., Haagensen, J. A. J., Sommer, L. M., Molin, S., & Johansen, H. K. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00477-5 · Cited by 525
Self-citationA novel colistin adjuvant identified by virtual screening for ArnT inhibitors
Ghirga, F., Stefanelli, R., Cavinato, L., Lo Sciuto, A., Corradi, S., Quaglio, D., Calcaterra, A., Casciaro, B., Loffredo, M. R., Cappiello, F., et al. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa200 · Cited by 28
Metadata
- Authors
- Jochumsen, N., Marvig, R. L., Damkiær, S., Jensen, R. L., Paulander, W., Molin, S., Jelsbak, L., & Folkesson, A.
- Venue
- Nature Communications
- Published
- 2016-10-03
- Volume
- 7
- Issue
- 1
- Pages
- 13002-13002
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2529078122
- Cited by
- 147
- References
- 4
- FWCI
- 9.54
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The evolution of antimicrobial peptide resistance in Pseudomonas aeruginosa is shaped by strong epistatic interactions. https://app.cochat.ai/papers/10.1038/ncomms13002
- The paper
- Jochumsen, N., Marvig, R. L., Damkiær, S., Jensen, R. L., Paulander, W., Molin, S., Jelsbak, L., & Folkesson, A. (2016). The evolution of antimicrobial peptide resistance in Pseudomonas aeruginosa is shaped by strong epistatic interactions. Nature Communications. https://doi.org/10.1038/ncomms13002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.